CannabisNewsBreaks Archive - Page 8 of 429

ThursdayMay 23, 2024 12:36 pm

CannabisNewsBreaks – CWCBExpo Continues Collaboration with CannabisNewsWire, IBN to Enhance Visibility of Upcoming Expo

CWCBExpo (Cannabis World Congress & Business Exposition), a market-leading and sector-shaping event series in the cannabis, CBD and hemp space, has selected CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 60+ brands of IBN (“InvestorBrandNetwork”), as the Official NewsWire sponsor to enhance visibility and recognition of its upcoming expo. In addition, CWCBExpo has selected IBN as the Official Media Sponsor of the event, scheduled to be held at New York City’s Javits Convention Center on June 5-6, 2024. According to the announcement, IBN and CNW will work in conjunction to leverage IBN’s extensive array…

ThursdayMay 23, 2024 11:58 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is partnering with a contract research organization (“CRO”) to conduct its human pilot study #3. According to the announcement, this is the first-ever DehydraTECH(TM)-processed tirzepatide from Zepbound(R) to be tested in a swallowed oral format. The study is designed to evaluate a dual-action GLP-1 (glucagon-like peptide) plus GIP (glucose-dependent insulintropic peptide) in a randomized, crossover investigation that will compare injected Zepbound tirzepatide by Eli Lilly to a compound formulated, DehydraTECH-processed tirzepatide that is derived from Zepbound but in a capsule form. Test articles for the study will be manufactured…

WednesdayMay 22, 2024 2:59 pm

CannabisNewsBreaks – AROYA Marks Release of 100th Episode of ‘Office Hours Live,’ Designed to Provide Cannabis Cultivation Guidance, Support and Community

AROYA, the leading cannabis cultivation platform, has reached a significant milestone for “Office Hours Live,” its popular podcast series. According to the announcement, “Office Hours Live” recently released its 100th episode, with each episode focused on providing free, science-based and expert-approved guidance on cannabis cultivation. Hosted by cannabis cultivation experts Seth Baumgartner and Jason Van Leuven, the series has had millions of views and downloads worldwide, answered more than 900 cultivator questions and featured 13 guests from various sectors of the cannabis industry; the episodes also include live question-and-answer segments where participants can interact directly with the hosts. “We created…

WednesdayMay 22, 2024 2:52 pm

CannabisNewsBreaks – CWCBExpo Names Josh Kesselman as Keynote Speaker for 10th Annual Trade Show and Conference

Cannabis World Congress & Business Exposition (“CWCBExpo”), the premier East Coast trade show and conference dedicated to the legalized cannabis industry, has announced the keynote speaker for next month’s event. According to the announcement, Josh Kesselman, iconic CEO and philanthropic founder of HBI International, will provide the main address. HBI International is the company behind RAW Rolling Papers. The CWCB Expo is scheduled for June 5–6, 2024, in New York City. Kesselman will open the event, presenting on the main stage at 11 a.m. ET on June 5; his presentation, which will be styled after a fireside chat, will be hosted by…

WednesdayMay 22, 2024 1:17 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Granted Two New US Patents in Hypertension, Epilepsy

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received two new patent awards, bringing the company’s patent portfolio to 43 granted patents worldwide. According to the announcement, the company has been granted a patent in its patent family #21, “Compositions and Methods for Treating Hypertension.” The company noted that this is the third granted U.S. patent in this category and is regarding the company’s DehydraTECH(TM)-processed cannabidiol (“CBD”) and evidence of its ability to lower blood pressure in both acute dosing in hypertension as well as during a five-week study duration. In addition, Lexaria has received a granted patent…

TuesdayMay 21, 2024 3:54 pm

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Moving to Build Complete Entertainment Enterprise

Golden Triangle Ventures (OTC: GTVH) and its entertainment division, Lavish Entertainment, are positioning for opportunity. “Most recently, the company took a significant step forward in the development of Destino Ranch into a premier music, art destination with the acquisition of ABI Create, an innovative event management and production company. Founded by Marco Antonio Moreno, who was recently named president and COO of Lavish Entertainment, ABI Create has delivered high-quality productions for a range of large-scale installations at major music festivals, sporting events and conventions across the United States, including the NFL Super Bowl, San Diego and New York Comic Con…

FridayMay 17, 2024 2:52 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Commencement of Dosing in Comprehensive GLP-1 Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, reported that dosing has begun in its 12-week animal study, WEIGHT-A24-1. The study is designed to model diabetes treatment and weight-loss effects of DehydraTECH(TM)-processed glucagon-like peptide 1 drugs and DehydraTECH-processed cannabidiol (“CBD”), both alone and in combination in diabetic preconditioned rats. According to the announcement, several new areas of investigation are being explored in this study, including evaluating whether DehydraTECH-processed oral GLP-1 drugs are more effective than non-DehydraTECH-processed oral GLP-1 drugs in reaching brain tissue, improving weight loss and improving control of blood sugar. The study will also evaluate…

ThursdayMay 16, 2024 3:30 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Tap into Various Growing Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, has proven in numerous studies the ability of its patented DehydraTECH(TM) technology to increase bio-absorption compared to standard industry formulations, as well as reduce time of onset and deliver drugs more effectively across the blood-brain barrier. “DehydraTECH has a number of potential pharmaceutical applications, a testament to its versatility and overall effectiveness. The key factor that has played a role in its adoption is its unique ability to improve drug bioavailability, a critical marker and determinant of overall drug effectiveness,” a recent article reads. “With this technology, Lexaria…

WednesdayMay 15, 2024 3:46 pm

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Journeys Toward Creation of One-of-a-Kind Destination

Golden Triangle Ventures (OTC: GTVH) is a multifaceted consulting company that operates as a parent business pursuing ventures in the health, entertainment and technology sectors. GTVH and its entertainment division, Lavish Entertainment, are working with Cayenne Consulting on the strategic development of Destino Ranch. “Destino Ranch aims to redefine luxury entertainment and hospitality experiences. Set amid the breathtaking landscapes of the Mojave Desert, Destino Ranch will offer a unique blend of world-class entertainment, luxurious accommodations and immersive experiences. The destination location is designed to be an outdoor music and festival venue, immersive art installation and tourist attraction,” a recent article…

TuesdayMay 14, 2024 3:34 pm

CannabisNewsBreaks – Zoned Properties Inc. (ZDPY) Releases Q1 2024 Financial Results Showing 22% Revenue Growth

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, including legalized cannabis, released its financial results for Q1 2024, the period ended March 31; the company also noted recent business highlights. According to the report, financial highlights include revenues totaling $837,052 for the quarter ended March 31, 2024, compared to $688,024 million revenues for the same quarter 2023, representing an increase of 22%; net income of $96,473, or $0.01 per fully diluted share, as compared to a net loss of $309,648, or ($0.03) per fully diluted share, for the same quarter in 2023, representing…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

CannabisNewsBreaks